Mehr »
Samstag, 15.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien



24 h / 7 T
7 Tage



24 h / 7 T
7 Tage














Erweiterte Suche
PR Newswire
240 Leser
Artikel bewerten:

In-Vitro Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR: 5.24%|UnivDatos Market Insights

NOIDA, India, Sept. 18, 2020 /PRNewswire/ -- UnivDatos Market Insights released a report titled "In-Vitro Diagnostics Market by Product (Reagents and Instruments Services), Techniques (Immunoassay, Clinical Chemistry, Self-Monitoring of Blood Glucose (SMBG), Molecular Diagnostics, Hematology, Microbiology, Point-of-Care, Hemostasis), Application (Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disease, Others), End-User (Hospitals, Clinics & Laboratory, Home Care, Other Healthcare Facility), Usability (Disposable and Reusable) and Region (North America, Europe, Asia-Pacific and Rest of World) - Current Analysis and Forecast (2019-2025)." According to the analysis, the market was valued at US$ 68.92 billion in 2018 and is predicted to reach US$ 98.18 billion by 2025. The market registered a CAGR of 5.24% during the forecast period (2019-2025).

UnivDatos Logo

For detailed analysis on the Global In-Vitro Diagnostics browse through

Market Dynamics

The report put forward both quantitative and qualitative industry analysis. Qualitative factors include several drivers and opportunities. It was estimated by WHO that, the proportion of the burden of Noncommunicable diseases (NCDs) will reach 57% by 2020. They possess one of the biggest health challenges throughout the globe. It has also been estimated that by 2030, the global population aged 60?years or over will occupy more than 56%.The rising geriatric population also leads to an increase in age-related disorders thereby influencing the market growth. It is estimated that between 2015 and 2050, the population aged over 60 years will almost be doubled across the world.

For detailed analysis on the drivers in Global In-Vitro Diagnostics browse through

COVID-19 impact

In-vitro diagnostics (IVDs) tests are conducted on the samples obtained from the human body, such as mucous swabs from the inside of the back of the throat or nose, or blood extracted from a vein or fingertip. IVDs can detect COVID-19 or other such conditions and can be used to monitor a person's health to help cure, treat, or prevent diseases. Serology/Antibody Tests detect antibodies (e.g., IgM, IgG) to the SARS-CoV-2 virus. Witnessing the rise in cases and tests conducted across the world, it is estimated that the pandemic will certainly increase the demand for such tests, supplementing the growth of In-Vitro Diagnostics market growth.

For detailed analysis on the regulations in Global In-Vitro Diagnostics browse through

The report also highlights the regulations and reimbursement policy in several countries such as the US, China, India, Japan, Australia, and Europe. Cost and benefits of diagnostic testing have also been provided to offer the stakeholders with the overall scenario as most treatment decisions today are based on IVD results.

By Product, the market is primarily bifurcated into

  • Reagents
  • Instruments Services

Reagents are essential components of IVD kits. They consist of surfactants, buffers, dyes, and basic chemicals. These reagents are used for setting up a reaction to the diagnosis of the disease. Special chemistry testing laboratories and clinical chemistry laboratories use them for an accurate diagnosis. Reagents dominated the product segment of the global In-Vitro Diagnostics market with a 69% share in 2018.

By Technique, the market is primarily bifurcated into

  • Immunoassay
  • Clinical Chemistry
  • Self-Monitoring of Blood Glucose (SMBG)
  • Molecular Diagnostics
  • Hematology
  • Microbiology
  • Point-of-Care
  • Hemostasis

Among techniques, Immunoassay occupied the largest share of 24.7% in 2018 and is expected to maintain its dominance throughout the forecast period 2019-2025. Immunoassay is deployed for the diagnosis of several infectious diseases. The popularity of SMBG is also increasing for keeping a regular check on the blood glucose level, as the diabetic population is increasing globally.

By Application, the market is primarily bifurcated into

  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disease
  • Others

In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is anticipated to witness growth with a CAGR of 4.89% during the forecast period 2019-2025. Moreover, the escalating prevalence of these diseases will increase the application of IVD for their detection. For instance, it has been estimated that 9.3% (463 million people) globally were suffering from diabetes. This figure is estimated to reach 10.9% (700 million) by 2045.

For detailed analysis on the applications of Global In-Vitro Diagnostics browse through

By End-User, the market is primarily bifurcated into

  • Hospitals
  • Clinics & Laboratory
  • Home Care
  • Others

IVD is used in hospitals, clinics & laboratories, home care, and other healthcare facilities The hospital is the major end-user of IVD and registered the maximum market growth. Point of care tests are compact such as pregnancy strips, fertility tests, and can be used in home settings. The results are provided by these tests much earlier as compared to the traditional tests.

By Usability, the market is primarily bifurcated into

  • Disposable IVD Devices
  • Reusable IVD Devices

The Reusable IVD Devices occupied the largest share and is projected to maintain its dominance throughout the forecast. These IVD devices can be used again after thorough cleaning and disinfection.

For detailed analysis on the usability of Global In-Vitro Diagnostics browse through

Global In-Vitro Diagnostics Market Geographical Segmentation Includes:

  • North America (United States, Canada and Rest of NA)
  • Europe (Germany, United Kingdom, France, Italy, Spain and Rest of Europe)
  • Asia-Pacific (China, Japan, India, Australia and Rest of APAC)
  • Rest of World (Brazil and Other Rest of World)

Based on the estimation, North America dominated the In-Vitro Diagnostics market. Rising incidence of chronic diseases, escalating geriatric population, and high healthcare spending are major factors attributed to this dominance. Moreover, the presence of several players in the region also provides the country with a first-mover advantage.

Request for the sample of the Report browse through

The major players targeting the market includes

  • Abbott Laboratories
  • Becton Dickinson
  • Biomérieux SA
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation
  • Johnson & Johnson
  • Roche Holding AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific
  • Sysmex Corporation

The competitive landscape has been provided pointing out the position of the key market players in the market along with the market share that is held by major players. These players are constantly working on expanding the market reach through M&A's along with partnerships.

UnivDatos Market Insights Pvt. Ltd.
4th & 5th Floor,
C80B, Sector 8, Noida,
Pin code- 201301, UP, India
Ph: +91 7838604911


Kostenloser Wertpapierhandel auf
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.